AcquiredStartups
Biggest in Merck Global Health Innovation Fund
Investor

Merck Global Health Innovation Fund

2Exits tracked$1.6bnDisclosed value$1.05bnMedian price0Acquihires

Startups backed by Merck Global Health Innovation Fund that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.

Photo: Goldmund100 / Wikimedia Commons, CC BY-SA 3.0
Healthtech & bio · Santa Cruz

argenx agrees to buy Unnatural Products for $550 million upfront to add oral peptide drug discovery

The two companies had worked together for more than two years, and argenx already owned part of the Santa Cruz biotech. The full price could reach about $1.15 billion if development and regulatory milestones are met.

Price$550mRaised$77mLast stageSeries BBuyer typeCorporate